Diseases, Conditions, Syndromes

Study uncovers clues to COVID-19 in the brain

A study by University of Cincinnati researchers and three Italian institutions reviewing neuroimaging and neurological symptoms in patients with COVID-19 may shed light on the virus's impact on the central nervous system.

Psychology & Psychiatry

Studies show men view 'traditional' depression as more severe

People around the world are isolating themselves to help slow the spread of COVID-19, but the crisis can heighten depression for those whose isolation has weakened their social support systems. Yet trends suggest men will ...

Medical research

Experimental drug shows promise for schizophrenia

An experimental drug may ease a range of symptoms that strike people with schizophrenia, without the side effects of existing medications, an early clinical trial suggests.

Medications

FDA: Asthma drug Singulair to get 'black box' warning

Asthma and allergy drug montelukast—sold as a generic and under the brand name Singulair—will get a "boxed warning" over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced Wednesday.

Psychology & Psychiatry

Genetics contributes to mental health risks in adoptees

The adoption of children is a fundamental method of building families. However, adoptees may face subsequent adaptive challenges associated with family stress at the time of birth and during the adoption process.

page 33 from 40